Amanta Healthcare Ltd

Amanta Healthcare Ltd

$AMANTAPharmaceuticalsNSEBSE

Amanta Healthcare Ltd (AMANTA) last traded at ₹195, a market capitalisation of ₹757 crore, on a P/E of 49.3. Over the past 52 weeks the stock has ranged between ₹92 and ₹206. Amanta Healthcare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹68.8 crore and net profit of ₹3.31 crore. Amanta Healthcare Ltd’s annual general meeting is scheduled for 16 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Amanta Healthcare Ltd share price and key metrics

Current price
₹195
Market cap
₹757 cr
Stock P/E
49.3
Book value
₹56.7
ROE
10.4%
ROCE
11.6%
Dividend yield
0.00%
52w high / low
206/92.0

Metrics as of 25 Aug 2026. Not real time.

Amanta Healthcare Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹68.8 cr, up 5.3% from ₹65.31 cr a year earlier. Net profit was ₹3.31 cr, down 5.7% year on year.

Amanta Healthcare Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales66.7367.8172.0665.3170.8974.4976.9968.8
Expenses52.8552.7553.150.4156.2459.1362.0354.26
Operating profit13.8815.0618.9614.914.6515.3614.9614.54
OPM %20.80%22.21%26.31%22.81%20.67%20.62%19.43%21.13%
Other income0.210.870.160.96-2.560.681.660.64
Interest6.325.96.286.295.155.064.256
Depreciation4.64.514.694.644.664.674.754.69
Profit before tax3.175.528.154.932.286.317.624.49
Tax %28.71%22.64%26.87%28.80%46.93%26.47%27.43%26.28%
Net profit2.264.285.963.511.214.635.533.31
EPS (₹)0.781.482.071.220.311.191.420.85

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Amanta Healthcare Ltd annual results

Amanta Healthcare Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales171225259280275288291
Operating profit38525358606060
OPM %22%23%20%21%22%21%20%
Net profit-2255-24101515
EPS (₹)-8.1420.54-0.791.353.643.833.77

TTM is the trailing twelve months to the most recent quarter.

Amanta Healthcare Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
11%
3 Years
4%
TTM
7%
Compounded Profit Growth
10 Years
%
5 Years
22%
3 Years
114%
TTM
-4%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
%
1 Year
%
Return on Equity
10 Years
%
5 Years
4%
3 Years
10%
Last Year
10%

Amanta Healthcare Ltd shareholding pattern

Promoters held 63.79% at Jun 2026, broadly unchanged since Sep 2025. FIIs 0.43% and DIIs 12.92%.

Amanta Healthcare Ltd shareholding pattern by quarter, in percent
% heldSep 2025Dec 2025Mar 2026Jun 2026
Promoters63.56%63.56%63.72%63.79%
FIIs1.00%1.10%0.85%0.43%
DIIs11.34%11.24%12.88%12.92%
Public24.10%24.09%22.55%22.84%
No. of shareholders18,66916,18115,22212,612

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Amanta Healthcare Ltd’s AGM?

Amanta Healthcare Ltd’s annual general meeting is scheduled for 16 Sept 2026.

  • AGM31st Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Amanta Healthcare Ltd corporate filings

  • Newspaper Advertisement for dispatch of Annual Report of the 31st Annual General Meeting and e-voting informationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare has published a newspaper advertisement regarding the dispatch of its…

    Read the full analysis
  • Annual Report for Financial Year 2025-26Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare has filed its Annual Report for the financial year 2025-26, dated…

    Read the full analysis
  • Notice of 31st Annual General Meeting and Annual Report for F.Y. 2025-26AGM/EGMhigh impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Limited has issued an intimation for its 31st Annual General Meeting…

    Read the full analysis
  • Annual Report for Financial Year 2025-26Otherslow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare has filed its Annual Report for the financial year 2025-26. The report…

    Read the full analysis
  • Submission of Newspaper clippings - Advertisement addressed to the Shareholders for Annual General MeetingCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Ltd has submitted newspaper clippings regarding the advertisement for…

    Read the full analysis
  • Earnings Call Transcript for quarter ended June 30, 2026Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare reported Q1 FY27 revenue of INR69 crore, a 5% YoY growth, with an…

    Read the full analysis
  • Monitoring Agency Report for the quarter ended June 30, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Ltd has filed its Monitoring Agency Report for the quarter ended June…

    Read the full analysis
  • Publication of Financial Results in NewspapersCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Limited has released its unaudited financial results for the quarter…

    Read the full analysis
  • Submission of Audio Recording of Post Results Conference Call held on August 6, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Limited has formally submitted the audio recording of its post-results…

    Read the full analysis
  • Announcement under Reg 30- Press ReleaseCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Ltd has filed a press release under Regulation 30 of the SEBI (LODR)…

    Read the full analysis
  • Statement of Deviation or Variation in utilization of funds, if anyCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Ltd has submitted a statement regarding the utilization of funds under…

    Read the full analysis
  • Investor PresentationCompany Updatemedium impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Limited reported Q1FY27 revenue of INR 69 crore, a 6% increase from INR…

    Read the full analysis
  • To approve unaudited Financial Results for the Quarter ended 30th June 2026Resulthigh impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Limited reported a decline in financial performance for the quarter…

    Read the full analysis
  • To approve unaudited Financial Results for quarter ended 30th June 2026Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare reported a weak performance for the quarter ended June 30, 2026, with…

    Read the full analysis
  • Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for change in Senior Management Personnel of the CompanyCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Amanta Healthcare Limited has formally included Mr. Nilesh Punjabi, Assistant Vice…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Amanta Healthcare Ltd

Cruxal reads every Amanta Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Amanta Healthcare Ltd (AMANTA) Results, Financials & Share Price | Cruxal